Can elevated prolactin (hyperprolactinemia) cause infertility?

Yes, increased prolactin definitively causes infertility in both women and men.

Elevated prolactin (hyperprolactinemia) is a well-established endocrine cause of infertility that disrupts the hypothalamic-pituitary-gonadal axis, leading to anovulation in women and impaired spermatogenesis in men 1.

Mechanism of Infertility

Hyperprolactinemia causes infertility through several pathways:

• In women: High prolactin levels suppress GnRH pulsatility, leading to chronic anovulation, luteal phase defects, amenorrhea, and oligomenorrhea 2, 3
• In men: Elevated prolactin impairs spermatogenesis, reduces sperm count and motility, and causes hypogonadism 1, 4

The reproductive system in women is particularly sensitive to even mild elevations in prolactin, while men require more significant and chronic elevations to manifest reproductive dysfunction 2.

Clinical Impact and Treatment Efficacy

The Endocrine Society guidelines clearly establish that dopamine agonist therapy restores gonadal function in patients with prolactinomas 1. The evidence demonstrates:

• Cabergoline restored menses in 82% of women with amenorrhea in placebo-controlled studies 1
• In men, 6 months of cabergoline treatment restored sperm count and motility 1
• Pregnancy rates of 60-80% can be achieved when hyperprolactinemia is the sole cause of infertility 5

Treatment Algorithm

1. Confirm persistent hyperprolactinemia with a second measurement (avoiding venipuncture stress) 1
2. Exclude macroprolactin in asymptomatic patients to avoid unnecessary treatment 1
3. Rule out secondary causes: medications (antipsychotics, metoclopramide), hypothyroidism, renal failure 1
4. Obtain pituitary MRI if prolactin >100 ng/mL or if symptoms suggest tumor 1

Treatment Recommendations

For symptomatic patients with prolactinomas or idiopathic hyperprolactinemia causing infertility, initiate cabergoline as first-line therapy 1, 6. Cabergoline is superior to bromocriptine with:

• Higher efficacy in normalizing prolactin (92% in microprolactinomas, 77% in macroadenomas) 1
• Better tolerability and compliance 1
• Typical dosing: 0.25-2 mg weekly, occasionally up to 3 mg/week 1

Treatment should be discontinued once pregnancy is confirmed 1, as the risk of tumor growth during pregnancy is low (<5% for microprolactinomas) 6.

Important Caveats

• Mild hyperprolactinemia (slightly above normal) can still cause luteal insufficiency and recurrent miscarriage in women, warranting treatment in those attempting conception 2
• Medication-induced hyperprolactinemia: First attempt to discontinue or switch the offending agent before considering dopamine agonist therapy, particularly with antipsychotics where treatment may exacerbate psychosis 1
• Asymptomatic microprolactinomas without fertility concerns do not require treatment 1

The evidence is robust for women but less extensive for men, though treatment principles remain similar when hyperprolactinemia causes documented reproductive dysfunction 2.